To investigate the role of recombinant bactericidal/permeability-increasing protein (rBPI 21 ) in the attenuation of the sepsis syndrome and acute lung injury associated with lower limb ischemia-reperfusion (I/R) injury.
Summary Background Data
Gut-derived endotoxin has been implicated in the conversion of the sterile inflammatory response to a lethal sepsis syndrome after lower torso I/R injury. rBPI 21 is a novel antiendotoxin therapy with proven benefit in sepsis.
Methods
Anesthetized ventilated swine underwent midline laparotomy and bilateral external iliac artery occlusion for 2 hours followed by 2.5 hours of reperfusion. Two groups (n ϭ 6 per group) were randomized to receive, by intravenous infusion over 30 minutes, at the start of reperfusion, either thaumatin, a control-protein preparation, at 2 mg/kg body weight, or rBPI 21 at 2 mg/kg body weight. A control group (n ϭ 6) underwent laparotomy without further treatment and was administered thaumatin at 2 mg/kg body weight after 2 hours of anesthesia. Blood from a carotid artery cannula was taken every halfhour for arterial blood gas analysis. Plasma was separated and stored at Ϫ70°C for later determination of plasma tumor necrosis factor (TNF)-␣, interleukin (IL)-6 by bioassay, and IL-8 by enzyme-linked immunosorbent assay (ELISA), as a markers of systemic inflammation. Plasma endotoxin concen-tration was measured using ELISA. Lung tissue wet-to-dry weight ratio and myeloperoxidase concentration were used as markers of edema and neutrophil sequestration, respectively. Bronchoalveolar lavage protein concentration was measured by the bicinclinoic acid method as a measure of capillary-alveolar protein leak. The alveolar-arterial gradient was measured; a large gradient indicated impaired oxygen transport and hence lung injury.
Results
Bilateral hind limb I/R injury increased significantly intestinal mucosal acidosis, intestinal permeability, portal endotoxemia, plasma IL-6 concentrations, circulating phagocytic cell priming and pulmonary leukosequestration, edema, capillary-alveolar protein leak, and impaired gas exchange. Conversely, pigs treated with rBPI 21 2 mg/kg at the onset of reperfusion had significantly reduced intestinal mucosal acidosis, portal endotoxin concentrations, and circulating phagocytic cell priming and had significantly less pulmonary edema, leukosequestration, and respiratory failure.
Conclusions
Endotoxin transmigration across a hyperpermeable gut barrier, phagocytic cell priming, and cytokinemia are key events of I/R injury, sepsis, and pulmonary dysfunction. This study shows that rBPI 21 ameliorates these adverse effects and may provide a novel therapeutic approach for prevention of I/Rassociated sepsis syndrome.
Despite successful surgery and intensive care support, ruptured abdominal aortic aneurysm repair carries a death rate of 50% to 75%. 1, 2 Adult respiratory distress syndrome with or without associated multiple organ failure is the primary cause of 20% such deaths and a contributory cause of the remainder. [2] [3] [4] Previous work has shown the central role for ischemia-reperfusion (I/R) injury in pathogenesis.
Reperfusion of the ischemic lower torso initiates a systemic inflammatory response syndrome characterized by proinflammatory cytokine 3, 5 and increased circulating polymorphonuclear leukocyte (PMN) activation. 6 Pulmonary 4 sequestration of activated neutrophils is followed by acute pulmonary microvascular injury, 7, 8 adult respiratory distress syndrome, 4 and a high subsequent death rate. 2 High circulating levels of proinflammatory cytokines responsible for leukocyte activation (e.g., tumor necrosis factor [TNF]-␣, interleukin [IL]-6, IL-8) 6 as well as endotoxin 9 have been shown after abdominal aortic aneurysm repair. 5, 10 We and others have previously shown that lower limb I/R injury is associated with increased intestinal permeability and endotoxemia. 5, 11, 12 Endotoxin is a lipopolysaccharide component of the gram-negative bacterial cell wall that provides potent stimulation of cytokine production and leukocyte activation. 13, 14 Its precise role in systemic sepsis syndrome after vascular surgery remains controversial. 5 Bactericidal/permeability-increasing protein (BPI) is an antibacterial protein isolated from human neutrophils 15 that binds lipopolysaccharide, inhibits leukocyte activation, lyses or kills bacteria, and ameliorates endotoxin effects. [15] [16] [17] The recombinant N-terminal fragment of this protein (rBPI 21 ) retains similar activity. 17 BPI inhibits lipopolysaccharide-induced neutrophil activation and cytokine secretion 18 and decreases tissue PMN deposition. 19 Recent work has shown that recombinant amino-terminal fragments and analogs of BPI (rBPI 21 and rBPI n ) increased survival, reduced cytokine production, and decreased the hemodynamic and metabolic derangement associated with lethal endotoxin challenge, 20 although human benefits are unclear. 21 We hypothesize that transmigration of endotoxin across a hyperpermeable intestinal barrier, proinflammatory cytokine levels, and remote PMN-mediated acute lung injury after lower limb I/R injury may be ameliorated by rBPI 21 pretreatment. In this study, we have tested this hypothesis in a porcine model of lower limb I/R against endpoints of endotoxemia, cytokinemia, and parameters relevant to acute lung injury.
METHODS

Experimental Protocol
These studies were performed in accordance with the Animals (Scientific Procedures) Act of 1986 and with the approval of our institution's Animals Research Committee. Immature male large white Landrace pigs (28 -35 kg; 6 -8 weeks old) were deprived of food other than water overnight before surgery.
Anesthesia and Ventilation
Pigs were sedated with intramuscular Stresnal (azaperone BP; 2-3 mg/kg) and anesthesia was induced with intravenous Sagatal (sodium pentobarbital; 20 mg/kg) and maintained with a continuous intravenous infusion of Sagatal (8 mg/kg/h), titrated to maintain apnea. After creation of a tracheostomy with insertion of a 7.5F endotracheal tube, mechanical ventilation (tidal volume 15 mL/kg) was instituted with an anesthesia machine. The ventilatory rate was adjusted to maintain the arterial partial pressure of CO 2 (PaCO 2 ) at 30 to 42 mmHg. End-expiratory pressure was zero. The fraction inspired O 2 (FiO 2 ) concentration was adjusted according to the experimental protocol. A continuous infusion of compound sodium lactate (Hartmann's solution; Baxter Healthcare Ltd., London, UK; 15 mL/kg/h) was given from induction of anesthesia throughout the experiments. Heating blankets were used to ensure body temperature of 38.2 Ϯ 0.8°C, monitored by rectal probe and a Model 7835A Hewlett-Packard Patient Monitor (Andover, MA).
Physiologic Measurements
The left carotid artery was exposed surgically and vascular polyethylene catheters (PE-190; Thomas, Philadelphia, PA) were positioned in the left external carotid artery. Continuous arterial blood pressure was monitored by electronic transduction. Intermittent arterial blood gas sampling and systemic blood sampling were carried out. A balloontip pulmonary artery catheter was advanced through the left external jugular vein and guided into the pulmonary artery by pressure waveform analysis for monitoring of central venous pressure, mean pulmonary artery pressure, and intermittent pulmonary arterial wedge pressure. Mean pressures were determined using calibrated physiologic pressure transducers (Model 1280C) driving an amplifier monitor (Model 7835A; Hewlett-Packard). The left cephalic vein was exposed surgically and a vascular polyethylene catheter (PE-160; Thomas) was inserted for continuous intravenous infusions of sodium pentobarbital (0.06 mg/kg/min) and compound sodium lactate solution.
Surgical Procedures
After a midline laparotomy incision was made, a 14-FG silicon urinary catheter was placed in the bladder through a cystostomy and secured in place with a purse-string suture for measurement of hourly urine output. A 7F catheter was advanced through the splenic vein to the portal vein for blood sampling. Its position was confirmed by palpating the tip of the catheter through the wall of the portal vein. Tonometers (Tonometrics Inc., Bethesda, MD) were placed in the gastric antrum and sigmoid colon by the endoluminal route, and in the terminal ileum through an enterotomy situated approximately 20 cm from the ileocecal junction. After hemostasis was ensured, the laparotomy was closed. The surgical procedures took approximately 60 minutes. Thereafter, pigs were allowed to stabilize for 30 minutes, as defined by constant heart rate, arterial pressure, and endtidal CO 2 .
Pressure Measurements
Intravascular pressure readings were obtained every 15 minutes for core temperature, mean arterial blood pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, and central venous pressure.
Blood Gas Measurements
Blood was obtained every 30 minutes from the carotid artery for measurements of arterial partial pressure of O 2 (PaO 2 ), PaCO 2 , and O 2 content. The gas analysis of the arterial sample were performed in an automatic blood gas analyzer (Model 1304 pH/blood gas analyzer, Instrumentation Laboratory, Warrington, UK) without delay. FiO 2 was measured in a ventilatory circuit using a 4700 Oxycap Monitor (Ohmeda, Louisville, CO). The arterial-alveolar (A-a) gradient was measured using the formula [(A-a) gradient ϭ FiO 2 ϫ 710 -(arterial pCO 2 /0.8) -arterial PO 2 ]. A large (A-a) gradient indicates impaired oxygen transport and hence lung injury.
Tonometry
Saline solution (5 mL at room temperature) was injected into the tonometer balloons and left for 30 minutes. At the end of this equilibration period, saline was removed according to the manufacturer's instructions and saline PCO 2 was measured immediately with the automatic blood gas analyzer. With the conversion table supplied by the manufacturer, measured PCO 2 was transposed to a steady-state PCO 2 depending on the exact duration of equilibration (correction factor ϭ 1.13; equilibrium time 30 minutes). Gut mucosal pH was calculated substituting the PCO 2 and the simultaneously measured arterial bicarbonate in the Henderson-Hasselbalch equation, pHi ϭ 6.1 ϩ log 10 ([HCO 3 ]/(0.03 ϫ PCO 2 ss)), where 6.1 accounts for HCO 3 Ϫ pK value at 37°C, [HCO 3 Ϫ ] is the measured arterial blood bicarbonate concentration (mmol/L), PCO 2 ss is the steady-state time-adjusted PCO 2 (mmHg) of tonometer saline, and 0.03 is the CO 2 solubility coefficient in plasma (mmol/L/mmHg) at 37°C. 22 
Intestinal Permeability
Intestinal permeability was assessed by measuring the urinary excretion of lactulose and mannitol. After an 8-hour fast, the test solution (5 g lactulose and 10 g mannitol dissolved in 50 mL distilled water) was instilled via a previously inserted gastric tube. The bladder was emptied and subsequently all urine was collected for a 6-hour period. The volume of urine was measured and aliquots of this and the pretest sample were stored at Ϫ20°C until assayed. The concentrations of lactulose and mannitol were measured enzymatically by the reduced nicotinamide adenine dinucleotide (phosphate)-linked enzymatic assays, modified from techniques described by Lunn et al, 23 using a Cobras Fara centrifugal analyser (Roche Diagnostics, Welwyn Gar-den City, UK). The amount of lactulose and mannitol excreted was calculated as a percentage of the administered dose, and intestinal permeability was expressed as the lactulose-to-mannitol ratio.
Experimental Design
Basal values were recorded after the 30-minute recovery period. Animals were randomized into three groups (n ϭ 6 per group). Two groups underwent bilateral external iliac artery occlusion by application of bulldog arterial clamps for 120 minutes followed by 150 minutes of reperfusion on release of bulldog clamps. Absence of flow, and restoration when appropriate, was confirmed using an ultrasonic flow probe (Transonic Systems Inc., Ithaca, NY) applied to the vessel wall. Six pigs were allocated as sham controls and kept for 270 minutes with recordings as for the experimental animals (see below).
Treatment
Animals undergoing bilateral hind limb ischemia were randomized to receive treatment with either rBPI 21 (Xoma [US] LLC, Berkeley, CA; 2 mg/kg body weight by intravenous infusion over 30 minutes from the beginning of reperfusion) or thaumatin, a control-protein preparation 24 (2 mg/kg body weight administered by intravenous infusion over 30 minutes from the beginning of reperfusion). The control group also received thaumatin (2 mg/kg body weight) at the same time points.
Blood and Tissue Sampling
Blood samples and measurements were taken every halfhour during the experimental period. Blood samples were collected in heparinized (20 units per milliliter blood), sterile pyrogen-free tubes. Samples were immediately transferred on ice to be centrifuged at 400 g (at 4°C) for 10 minutes. Plasma was then aliquoted into sterile cryotubes (Nunc, Intermed, Roskidle, Denmark) and stored at Ϫ70°C until the time of assay. Immediately after final blood samples were taken, each animal underwent a midline thoracotomy and samples of right lung were excised from predetermined sites. Separate samples were either fixed in 4% formalin or placed immediately in a sterile pyrogen-free cryotube (Nunc), snap-frozen in liquid nitrogen, and stored at Ϫ70°C until the time of histologic assessment or assay, respectively.
Bronchoalveolar Lavage
Bronchoalveolar lavage was performed through the endotracheal tube using a Silastic pulmonary suction catheter at 240 minutes, into the right lung. The distal end was wedged into third-or fourth-order bronchi of the middle and lower lobes. All lavages were performed by the same person, and catheter placement was confirmed on cadaver studies. Each lobe was washed with 50 mL sterile 0.9% sodium chloride; retrieval volumes consistently exceeded Vol. 234 • No. 2 rBPI 21 Attenuates Reperfusion Injury 50% of instilled volume. Lavage fluid was centrifuged at 400g at 4°C for 10 minutes, and the supernatant was stored at Ϫ20°C. The lavage protein content was measured in the noncellular fraction by the bicinclinoic acid method.
Luminol-Enhanced Chemiluminescence Assay
Chemiluminescence was assayed with an LKB Wallac Luminometer 1251 (Wallac Oy, Tusku, Finland). This instrument detects and records the number of photons released by luminol deoxygenation. Under the conditions used, this luminol-dependent chemiluminescence assay represents primarily PMN respiratory burst activity when applied to whole blood. To trigger a respiratory burst, assay tubes contained 100 L phorbol 12-myristate 13-acetate. Reactions were initiated by the automated injection of 600 L Luminol Complete medium into each reaction tube and 100 L blood (prediluted 1:40 in blood diluting medium). Some reaction tubes contained 47 pmol/L recombinant human TNF-␣ receptor fusion protein. All chemiluminescence assays were performed in duplicate at 37°C.
Activity is reported as the integral of the chemiluminescence events registered during the initial 10 minutes of activation. The degree of respiratory burst activity is dependent on prior priming in vivo; further, by maximally priming some samples with addition of TNF-␣ to the diluted whole blood, a ratio could be determined between whole blood priming and whole blood ϩ TNF-␣, thus comparing in vivo priming with maximal priming.
Total White Cell Counts
Arterial blood samples were drawn into sterile glass tubes containing 0.15% acetic acid and kept at 4°C (Vacutainer, Becton Dickinson, Rutherford, NJ). Small aliquots of blood were set aside for white blood cell counts and blood smear differential cell counts that were performed as previously described. The remainder of the samples were centrifuged at 500g at 4°C for 20 minutes, and the resulting plasma was stored at Ϫ20°C.
Tumor Necrosis Factor-Alpha Assay
Biologically active TNF-␣ was bioassayed by an MTT tetrazolium-based cytotoxicity assay based on the TNF-␣sensitive WEHI 164 clone, as previously described. 25 Absorbance was then read at 570 nm, and the amount of TNF-␣ in each sample was computed from the standard curve. Interassay and intraassay coefficients of variation were less than 10%. The detection limit of the assay is 0.02 pg/mL TNF-␣.
Interleukin Assays
Biologically active IL-6 was measured using a bioassay based on the proliferation of IL-6-dependent B9 hybridoma cells (a generous gift of L. Aarden, Amsterdam), as previously described. 25 Absorbance was read at 570 nm, and the amount of IL-6 in each sample was computed from the standard curve. Interassay and intraassay coefficients of vari-ation were less than 10%. Plasma levels of IL-8 and IL-10 were analyzed by sandwich enzyme-linked immunosorbent assays (ELISAs) according to the instructions of the manufacturer (Biosource International Inc., Camarillo, CA).
Endotoxin
Endotoxin concentration was determined using a quantitative Limulus amebocyte lysate (LAL) chromogenic assay (Quadratech, Epsom, UK). Detection limits of the assay were 0.1 to 100 pg/mL, the interassay coefficient of variation was less than 10%, and the intraassay coefficient of variation was less than 10%.
Measurement of Lung Tissue Myeloperoxidase
The tissue specimen (200 -400 mg) was homogenized in HTAB buffer on ice. The pooled homogenate were sonicated for 10 seconds, freeze-thawed thrice, and centrifuged at 40,000g for 15 minutes. In the supernatant, myeloperoxidase activity was measured spectrophotometrically: 0.1 mL supernatant was combined with 2.9 mL of 50 mmol/L phosphate buffer (pH 6.0) containing 0.167 mg/mL Odianisidine hydrochloride and 0.0005% hydrogen peroxide. The change in absorbance at 460 nm was measured with a Beckmann DU-2 spectrophotometer (Beckmann Instruments, Inc., Cedar Grove, NJ). One unit of myeloperoxidase activity is defined as that degrading 1 micromol of peroxide per minute at 25°C.
Lung Tissue Wet-to-Dry Weight Ratios
Wet-to-dry ratios of lung and skeletal muscle tissue samples (200 -400 mg) were calculated. Each specimen was blotted dry, weighed, and then placed in a vacuum freeze-dryer at Ϫ70°C for 48 hours. Specimens were then reweighed and the wet-to-dry tissue weight ratio was calculated.
Statistical Analysis
Summary values are expressed as mean Ϯ standard error of the mean or median (interquartile range). One-way repeated measures analysis of variance was used to compare sequential measurements for parametric data. The Dunnett test was used to make further comparisons if analysis of variance revealed significant differences. The control value for the Dunnett test was designated as the last measurement obtained at the end of the baseline period (time 0). The Student t test was used for independent comparisons for parametric data. Kruskall-Wallis H analysis of variance was used in conjunction with the Mann-Whitney test for nonparametric comparisons. A two-tailed P Ͻ .05 was considered statistically significant.
To assess the degree of association between the variables, the Spearman rank correlation coefficient was calculated. Significance was taken at the 5% level. Statistical calculations were performed using SPSS (Version 9.0, Microsoft, Redmond, WA) software.
RESULTS
Physiologic and Hemodynamic Variables
Central venous pressure and pulmonary capillary wedge pressure did not change significantly from baseline throughout the experimental period. Mean arterial pressure was significantly greater in both I/R groups (P Ͻ .01) and the rBPI 21 -treated I/R group (P Ͻ .001) versus the control group during the ischemic period (t ϭ 0 -120) and remained significantly elevated in the rBPI 21 -treated I/R group during the reperfusion period versus the control group (P Ͻ .001) and the untreated I/R group (P Ͻ .01).
Arterial partial pressure of oxygen decreased significantly during the reperfusion period in the I/R group versus the control group (P Ͻ .05) and the rBPI 21 -treated I/R group (P Ͻ .01) ( Fig. 1 ). Pulmonary artery pressure was significantly greater during reperfusion in the I/R group versus the control group (P Ͻ .001) and the rBPI 21 -treated I/R group (P Ͻ .001). However, the pressure in the treated group remained significantly higher than in the control group (P Ͻ .02).
Alveolar-arterial O 2 gradient values were similar during the ischemia period but were significantly higher after reperfusion in the I/R group versus the control group (P Ͻ .05). This finding suggests impaired alveolar oxygen transport. This impairment in oxygen transport was prevented in the rBPI 21 -treated I/R group (P Ͻ .04).
Tonometry Measurements
Temporal changes in gastric mucosal pH, ileal mucosal pH, and sigmoid mucosal pH at baseline and for each time point during the experiment are shown in Figure 2 . A significant decrease was seen in ileal pHi during the reperfusion period (t ϭ 120 -270) in the untreated I/R group versus both the control group (P Ͻ .05) and the rBPI 21treated I/R group (P Ͻ .05). Sigmoid pHi decreased during the reperfusion period (t ϭ 120 -270) in the untreated I/R group versus the control group (P Ͻ .005) and the rBPI 21treated I/R group (P Ͻ .02).
Plasma Interleukin-6
Plasma IL-6 levels were significantly greater after 1 hour of reperfusion (t ϭ 180) in the I/R group, 1726.00 (1130.00 -2130.00) pg/mL, versus the control group, 303.50(274. 35-374.25 ) pg/mL (P Ͻ .003), or the rBPI 21treated I/R group, 362.5 (304.48 -452.58) (P Ͻ .001) ( Fig.  3 ). There was no significant difference in the plasma IL-6 level during reperfusion between the systemic, portal sampling sites.
Plasma Tumor Necrosis Factor-Alpha
Plasma TNF levels were significantly greater after 1 hour of reperfusion (t ϭ 180) in the I/R group, 86.83 (48.71-182.02) pg/mL, versus the control group, 32.67(0.95-42.82) pg/mL, and the rBPI 21 -treated group, 5.21 (1.88 -15.46) (P Ͻ .05). There was no significant difference in the plasma TNF level during reperfusion between the systemic, portal sampling sites (Fig. 4 ). 
Endotoxin Concentration, Portal Vein
Endotoxin concentrations were comparable in the I/R and control groups in the reperfusion period. In the I/R group, the endotoxin concentration in the systemic circulation decreased during reperfusion time points t ϭ 180, 11.30 (0.00 -61.00), and t ϭ 270, 16.20 (0.00 -49.60), versus the portal vein at t ϭ 180, 500 (28.00 -514.20) (P Ͻ .01), and t ϭ 270, 505.70 (92.00 -530.70) (P Ͻ .001), respectively ( Fig. 5 ).
Portal vein endotoxin concentration increased during the reperfusion period in the I/R group, 505.70 (92.00 -530.70) pg/mL, versus the control group, 18.92 (8.65-78.67) (P Ͻ .009). This effect was significantly attenuated in the rBPI 21 
Lung Tissue Ratio
The lung wet-to-dry tissue weight ratio was significantly greater in the I/R group, 10.13 (7.66 -12.66), versus the control group, 5.57 (4.54 -7.37) (P Ͻ .011). This increase was significantly attenuated in the rBPI 21 -treated I/R group, 6.46 (5.06 -7.28), versus the untreated I/R group (P Ͻ .02) ( Fig. 6 ).
Lung Tissue Myeloperoxidase
The lung tissue myeloperoxidase concentration was significantly greater in the I/R group, 33.81 (15.65-52.66) units of absorbance per gram dry tissue, versus the control group, 7.54 (0.97-8.63) (P Ͻ .005). This increase in the lung tissue myeloperoxidase concentration was significantly 
Lavage Noncellular Fraction Protein Concentration
The lavage protein concentration was significantly greater after 2 hours of reperfusion (t ϭ 240) in the I/R group, 0.73 (0.31-1.60), versus the control group, 0.23 (0.18 -0.31) (P Ͻ .05). This increase was significantly attenuated in the rBPI 21 -treated I/R group, 0.21 (0.20 -0.21), versus the untreated I/R group (P Ͻ .042).
The Spearman rank correlation for the myeloperoxidase and wet-to-dry ratio was P Ͻ .0001, r ϭ 0.57; the correlation for lavage protein and the wet-to-dry ratio was P Ͻ .05, r ϭ 0.389.
Lactulose/Mannitol Urinary Excretion Ratio
The lactulose/mannitol urinary excretion ratio was significantly greater in the I/R group, 0.191 Ϯ 0.03, versus the control group, 0.092 Ϯ 0.03 (P Ͻ .024) and versus the rBPI 21 -treated I/R group, 0.06 Ϯ 0.02 (P Ͻ .001). Data represents mean (standard error of the mean), comparisons with analysis of variance and the Student t test (Fig. 7 ). There was a significant (P Ͻ .008), positive correlation (r ϭ 0.604) between plasma portal endotoxin concentration and the lactulose/mannitol urinary excretion ratio by Spearman's rank correlation.
Whole-Blood Chemiluminescence
There was a significantly greater whole blood phagocytic priming ratio after 30 minutes of reperfusion (t ϭ 150) in the I/R group, 1.01 Ϯ 0.08, versus the control group, 0.56 Ϯ 0.11 (P Ͻ .033) and versus the rBPI 21 -treated I/R group, 0.62 Ϯ 0.06 (P Ͻ .009). After 2 hours of reperfusion (t ϭ 240), the priming ratio remained significantly greater in the I/R group, 0.86 Ϯ 0.14, versus the control group, 0.26 Ϯ 0.07 (P Ͻ .021) and the rBPI 21 -treated group, 0.54 Ϯ 0.07 (P Ͻ .05). The priming ratio decreased significantly in the control group from the start (t ϭ 0), 0.65 Ϯ 0.11, to the end (t ϭ 240), 0.26 Ϯ 0.07 (P Ͻ .005). A significant increase in priming occurred in the I/R group from t ϭ 0 to t ϭ 240, 0.58 Ϯ 0.06 versus 0.86 Ϯ 0.14 (P Ͻ .05) (Fig. 8A ). 
Whole Blood Leukocyte Counts
No difference in total whole blood leukocyte count at time zero and after 240 minutes was found between the control group, 15.55 (10.50 -24.97) ϫ 10 9 /L and 23.90 (20.91-25.75) ϫ 10 9 /L, or the I/R group, 13.56 (12.27-21.78) ϫ 10 9 /L and 20.94 (14.45-26 .91) ϫ 10 9 /L. Nor was there any difference in the neutrophil fraction between the control group and the I/R group at the start or the end of the experiment. Figure 8B shows the temporal changes in the plasma IL-8 concentration in the control group, the untreated I/R group, and the rBPI 21 -treated I/R group. After 1 hour of reperfusion (t ϭ 180), plasma IL-8 levels were elevated in the control group, 198.10 (116.10 -373.90) pg/mL, versus the I/R group, 42.42 (25.21-107.10) (P Ͻ .026), and the rBPI 21treated I/R group, 68.69 (64.68 -98.61) (P Ͻ .008).
Plasma Interleukin-8
Plasma Interleukin-10
After 1 hour of reperfusion (t ϭ 180) compared with the control group, 11.19 (6.75-14.11) pg/mL, plasma IL-10 levels were significantly elevated in the I/R group, 30.76 (19.56 -77.70) (P Ͻ .001), and the rBPI 21 -treated I/R group, 32.67 (24.63-42.10) (P Ͻ .001).
DISCUSSION
Our results show that a novel recombinant antilipopolysaccharide protein ameliorates the entire cell and molec- ular cascade of I/R-initiated sepsis syndrome. Invasive hemodynamic measurements and maintenance intravenous volume supplementation ensured that the large animal model remained normotensive throughout the experimental period. We used the dual sugar (lactulose and mannitol) absorption test, intestinal tonometry, and the LAL ELISA as indices of intestinal permeability and endotoxemia. We used plasma cytokinemia and luminol-enhanced whole blood chemiluminescence as indices of systemic inflammation and PMN activation. Lung tissue wet-to-dry weight, myeloperoxidase concentration, bronchoalveolar lavage protein concentration, and pulmonary physiologic measurements were used as indices of acute lung injury.
Ruptured abdominal aortic aneurysm repair is accompanied by I/R and carries a 50% to 75% death rate. 1 Increased levels of endotoxin, a lipopolysaccharide component of the wall of gram-negative bacteria, have been shown in the portal and systemic circulation of patients after aneurysm repair. 9, 26 The conversion of an essentially sterile I/R injury to a septic syndrome has led many to question the role of endotoxin and sepsis in the high death rate after ruptured aneurysm. 5, 27 Intestinal injury in this model was associated with a significant increase in gastric, ileal, and sigmoid mucosal acidosis during the reperfusion period. Further, intestinal permeability, assessed with the dual sugar absorption test, was significantly increased. Treatment with rBPI 21 at the start of the reperfusion period significantly attenuated the increase in intestinal permeability and intestinal mucosal acidosis and completely attenuated the concentration of portal endotoxin. It is not possible to tell whether the reduction in portal endotoxin concentration was due to decreased transmigration or increased leukocyte-mediated clearance of endotoxin. The gut has a large resident population of gram-negative bacteria, 28 and in health some endotoxin does enter the portal circulation without any major systemic inflammation. 29 The relevance of endotoxemia to the inflammatory response in vascular surgery has been questioned. 5, 26 Despite this, endotoxin is undoubtedly a potent stimulus to systemic inflammation and activation of PMNs. 13, 30 Woodcock et al 31 recently showed bacterial translocation in patients with abdominal aortic aneurysm and concluded that it increased septic complications. Treatment with rBPI 21 attenuated the intestinal mucosal acidosis, a reliable indicator of mucosal blood flow, in this model. Impaired splanchnic blood flow has been suggested as a cause of extended gut injury in sepsis. 32 Perhaps increased clearance or decreased transmigration of endotoxin into the microvasculature may decrease vasoconstriction. 26 Another possible explanation is that rBPI 21 treatment attenuates the IL-6 response, reduces systemic inflammation, and therefore reduces secondary hemodynamic and mediator-induced intestinal injury.
The sepsis syndrome secondary to endotoxemia remains a leading cause of death and complications. Initial optimism about the benefits of antiendotoxin immunotherapy 33 has given way to doubts about the clinical efficacy and indeed the endotoxin-binding properties of these antibodies. 34 BPI and its N-terminal fragments and analogs have certain advantages, being neither serotype-specific nor inhibited by the O-specific side chain of lipopolysaccharide. 16, 17 Their short plasma half-life makes the timing of drug delivery crucial. In vitro analogs of BPI have been shown to inhibit lipopolysaccharide-induced PMN activation and cytokine secretion. 18 Hansbrough et al 19 showed decreased tissue PMN deposition in a sterile acute burn injury model using recombinant BPI, suggesting that this effect may be medi- ated by inhibition of PMN activation. This finding may suggest that BPI and its analogs have beneficial effects in the absence of endotoxin. Recent reports on BPI (rBPI 21 and rBPI 23 ) have shown increased survival, reduced cytokine production, and decreased inflammatory response to lethal endotoxin challenge in animals. 20 Its beneficial effects in humans are still under debate. 35 High levels of TNF-␣, IL-1␤, IL-6, and IL-8 have been shown after abdominal aortic artery repair, 36 -38 and persistently high levels correlate with death. 39 We have shown small but significant elevations in plasma TNF-␣, a potent early proinflammatory mediator, in response to hind limb I/R. Treatment after ischemia with rBPI 21 attenuates the TNF-␣ response after 1 hour of reperfusion. Reperfusion of ischemic skeletal muscle increases TNF-␣ production in the absence of any septic stimulus. TNF-␣ has been implicated in the development of acute lung injury after lower limb I/R via induction of nitric oxide synthesis; injury can be prevented by TNF antagonists. 40 We have shown highly significant elevations in plasma IL-6 levels, most markedly throughout the reperfusion period. Treatment with rBPI 21 at the start of reperfusion completely abrogated this increased production of IL-6, a secondary mediator with both pro-and antiinflammatory activities, suggesting that prevention of endotoxin-induced inflammatory activation prevents progression to uncontrolled inflammation. Cytokines such as IL-6 have also been shown to inhibit PMN apoptosis in vitro and therefore may increase the functional longevity of such leukocytes and their ability to induce tissue injury. 36 IL-8 is a powerful chemoattractant cytokine, and its presence has been implicated in the development of acute lung injury after abdominal aortic artery repair. 37 We have shown significantly lower levels of IL-8 after I/R injury in this model versus control, unaffected by treatment with rBPI 21 . This is an unexpected finding, because IL-8 has been shown be a chemoattractant to PMNs, and levels are elevated in a variety of inflammatory states. Of interest, the levels of IL-10, a primarily antiinflammatory cytokine, were significantly elevated in the two I/R groups versus the control group. This may suggest a shift in the balance toward compensatory antiinflammatory response syndrome. IL-10 has been shown to decrease the amount of circulating proinflammatory mediators such as IL-1␤, TNF-␣, and IL-8. The administration of exogenous IL-10 has been shown to reduce local limb injury and to attenuate remote lung injury. 38, 41 From these data, it is not possible to confirm the source of the cytokines observed. It has been suggested that cytokine production by patients undergoing abdominal aortic artery surgery is a response to occult ischemia of the colon. 22, 26, 42 Lower limb I/R is associated with systemic endotoxemia; hence, a possible second source of cytokines is remote activation of enterocytes and gastrointestinal macrophages. 43, 44 In this study, ischemia was confined to the lower limb, indicating that lower limb I/R injury itself is the stimulus for cytokine production. Further, IL-6 concentrations were no greater in the portal circulation than in the systemic circulation. The continuous increase in IL-6 concentrations throughout the reperfusion period supports the finding of others that IL-6 production is proportional to the extent of reperfusion injury. 5, 39 Increased circulating PMN priming and activation have been shown after abdominal aortic artery repair. 6 The process whereby exposure to a plasma factor increases the capacity of PMNs to produce reactive oxidant species, in response to a secondary stimulus, is called priming. 45 In reperfusion injury, a variety of cytokines and mediators may be responsible for priming neutrophils. 45, 46 Luminol-dependent chemiluminescence of whole blood was developed to estimate the phagocytic function of granulocytes and the serum opsonic activity simultaneously. It measures reactive oxygen species production and neutrophil degranulation, which is specific and azurophilic. 46 We found in our model increased circulating whole blood phagocytic cell priming, and we also showed that treatment with rBPI 21 can attenuate this increase. This decreased priming and potential for respiratory burst-induced injury may explain the decreased intestinal and pulmonary injury.
In this study, the development of remote pulmonary dysfunction was observed only after reperfusion, with development of hypoxemia, pulmonary hypertension, and impaired oxygen transport. Humoral and/or cellular mediators may be implicated. 47 Neutrophil-mediated acute lung injury is suggested by elevated levels of lung tissue myeloperoxidase, lavage protein concentration, and wet-to-dry weight ratio. The prevention of this acute pulmonary dysfunction in the rBPI 21 -treated group suggests a role for endotoxininduced circulating neutrophil activation in the development of this lung injury. Of interest, the myeloperoxidase concentration in the rBPI 21 -treated I/R group was elevated compared with the control group, although neither one was significantly different from the control or untreated I/R group. However, there was significantly less edema and protein leakage in the treated group, perhaps suggesting that sequestered neutrophils are less primed and induce less tissue injury. Our findings are in agreement with previous reports of a varying degree of pulmonary dysfunction, characterized by increased microvascular permeability and leukocytic sequestration within the lung. 4 Early signs of adult respiratory distress syndrome have been reported within hours of aortic declamping in patients undergoing abdominal aortic artery repair 4 and animal models of reperfusion injury. 4, 48, 49 We witnessed a significant degree of pulmonary hypertension in our I/R group associated with the impaired alveolar oxygen transport, which has been shown in patients with adult respiratory distress syndrome. 28, 50 The importance of PMNs in acute lung injury after limb I/R has been confirmed in leukopenic models. 51 Although acute lung injury has been shown in PMN-depleted animals, 52 it is less severe, probably caused by vasoactive mediators such as thromboxane A2 and leukotriene B4. 53, 54 The mechanism whereby lung injury is primarily due to neutrophil adherence, sequestration, and subsequent respiratory burst-induced oxidative injury is supported by the observation that lung injury can be attenuated with anti-CD18 monoclonal antibodies 49 or by antioxidant preloading. 48 A growing body of evidence supports a role for gut hyperpermeability 55 and translocation of endotoxin in the propagation of the inflammatory response to abdominal aortic aneurysm surgery. If gut endotoxin converts a recoverable inflammatory response into a lethal endotoxemia in a certain subset of patients, then rBPI 21 may represent an important advance in the treatment of these patients.
In conclusion, we have shown that rBPI 21 can reduce endotoxemia and the production of TNF-␣ and IL-6. It significantly attenuates the remote acute pulmonary dysfunction seen after hind limb I/R injury. This is associated with a reduction in circulating neutrophil priming. We therefore conclude that rBPI 21 attenuates the systemic inflammatory response syndrome and lung injury associated with limb I/R by preventing a secondary hit septic (lipopolysaccharide) insult.
